← SynDRA
RS-102,221
SynDRA canonical compound SYN0003604 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | HTR2C |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- HTR2C ANTAGONIST
- HTR2C INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- HDAC6
- TDP1
- USP1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- RS-102221
- RS102221
- RS 102221 HCl
- Tocris-1050
- Biomol-NT_000133
- AC1MW45U
- GTPL187
- CHEMBL88402
- SCHEMBL7107338
- BPBio1_000243
- RS102221 HCl
- CHEBI:93519
- BDBM85098
- HZZZZODVDSHQRG-UHFFFAOYSA-N
- BCP03496
- ZINC26580328
- PDSP1_001633
- PDSP2_001617
- NCGC00024967-02
- NCGC00024967-01
- L000523
- BRD-K87048468-003-01-9
- N-{5-[5-(2,4-dioxo -1,3,8-triazaspiro[4.5]dec-8-yl)pentanoyl]-2,4-dimethoxyphenyl}-4-trifluoromethylbenzenesulfonamide
- RefChem:930931
- orb3027143
- DA-57544
- HY-101365
- BRD-K87048468-003-02-7
- RS 102221 Hydrochloride
- DK42AGJ62K
- H37226
- RS-102221 HCl
- RS102221;RS 102221
- FR103699
- RS-102221 (hydrochloride)
- SR-01000597830
- SR-01000597830-1
- SCHEMBL8815714
- RS102221 hydrochloride
Look up RS-102,221 in the interactive SynDRA portal →